| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
|
Garcia, Jacqueline S.
|
|
|
5 |
24 |
p. 5536-5545
|
article
|
| 2 |
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL
|
Greenwood, Matthew
|
|
|
5 |
24 |
p. 5574-5583
|
article
|
| 3 |
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
|
Carney, Brian J.
|
|
|
5 |
24 |
p. 5546-5553
|
article
|
| 4 |
A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy
|
Zhao, Peng
|
|
|
5 |
24 |
p. 5479-5489
|
article
|
| 5 |
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations
|
Montgomery, Nathan D.
|
|
|
5 |
24 |
p. 5612-5616
|
article
|
| 6 |
Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey
|
Valentini, Caterina Giovanna
|
|
|
5 |
24 |
p. 5608-5611
|
article
|
| 7 |
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
|
Yeh, Jason
|
|
|
5 |
24 |
p. 5599-5607
|
article
|
| 8 |
CAR T-cell therapy for secondary CNS DLBCL
|
Ahmed, Gulrayz
|
|
|
5 |
24 |
p. 5626-5630
|
article
|
| 9 |
Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
|
Forlenza, Christopher J.
|
|
|
5 |
24 |
p. 5519-5524
|
article
|
| 10 |
Consensus statement for the perinatal management of patients with α thalassemia major
|
MacKenzie, Tippi C.
|
|
|
5 |
24 |
p. 5636-5639
|
article
|
| 11 |
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
|
Olszewski, Adam J.
|
|
|
5 |
24 |
p. 5525-5535
|
article
|
| 12 |
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
|
Tedeschi, Alessandra
|
|
|
5 |
24 |
p. 5490-5500
|
article
|
| 13 |
Editorial Board
|
|
|
|
5 |
24 |
p. i
|
article
|
| 14 |
Evans syndrome in adults: an observational multicenter study
|
Fattizzo, Bruno
|
|
|
5 |
24 |
p. 5468-5478
|
article
|
| 15 |
Expanding the genetic spectrum of TUBB1-related thrombocytopenia
|
Palma-Barqueros, Verónica
|
|
|
5 |
24 |
p. 5453-5467
|
article
|
| 16 |
GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1
|
Singh, Preeti
|
|
|
5 |
24 |
p. 5631-5635
|
article
|
| 17 |
Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
|
Lázaro-Navarro, Juan
|
|
|
5 |
24 |
p. 5501-5506
|
article
|
| 18 |
KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints
|
Bataller, Alex
|
|
|
5 |
24 |
p. 5617-5620
|
article
|
| 19 |
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
|
Rodríguez, Marta
|
|
|
5 |
24 |
p. 5588-5598
|
article
|
| 20 |
Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes
|
LoCastro, Marissa
|
|
|
5 |
24 |
p. 5554-5564
|
article
|
| 21 |
Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients
|
Dennis, Mike
|
|
|
5 |
24 |
p. 5621-5625
|
article
|
| 22 |
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
|
Kitazawa, Hironobu
|
|
|
5 |
24 |
p. 5507-5518
|
article
|
| 23 |
The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia
|
Vucinic, Vladan
|
|
|
5 |
24 |
p. 5584-5587
|
article
|
| 24 |
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
|
Cherry, Evan M.
|
|
|
5 |
24 |
p. 5565-5573
|
article
|
Journal description